IRIS
PICARDI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 11.980
NA - Nord America 1.759
EU - Europa 882
SA - Sud America 44
AF - Africa 30
OC - Oceania 28
Totale 14.723
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 10.029
US - Stati Uniti d'America 1.663
CN - Cina 1.009
HK - Hong Kong 784
GB - Regno Unito 245
IT - Italia 190
DE - Germania 150
CA - Canada 65
FI - Finlandia 54
IN - India 54
NL - Olanda 46
BR - Brasile 37
PL - Polonia 33
TR - Turchia 29
FR - Francia 27
AU - Australia 26
ES - Italia 26
MX - Messico 26
CZ - Repubblica Ceca 25
UA - Ucraina 19
ZA - Sudafrica 19
JP - Giappone 15
RU - Federazione Russa 14
CH - Svizzera 11
VN - Vietnam 9
SE - Svezia 8
SA - Arabia Saudita 7
BE - Belgio 6
ID - Indonesia 6
BD - Bangladesh 5
DK - Danimarca 5
LT - Lituania 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
CL - Cile 4
BA - Bosnia-Erzegovina 3
IR - Iran 3
MA - Marocco 3
CM - Camerun 2
EE - Estonia 2
HU - Ungheria 2
IE - Irlanda 2
JO - Giordania 2
KR - Corea 2
KZ - Kazakistan 2
MW - Malawi 2
YE - Yemen 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
CY - Cipro 1
ET - Etiopia 1
GH - Ghana 1
GN - Guinea 1
HN - Honduras 1
HT - Haiti 1
IL - Israele 1
IQ - Iraq 1
IS - Islanda 1
KH - Cambogia 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MS - Montserrat 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
VG - Isole Vergini Britanniche 1
Totale 14.723
Salva come PNG Salva come JPEG
Città #
Hong Kong 767
Singapore 547
Hefei 494
Ashburn 396
Boardman 264
London 202
Shanghai 190
Beijing 147
Munich 87
Rome 78
Los Angeles 72
Council Bluffs 65
San Francisco 61
Dallas 56
West Jordan 41
Seattle 39
Toronto 38
Turku 33
Pune 32
Santa Clara 31
Warsaw 31
Washington 31
Amsterdam 25
Brno 22
Helsinki 21
New York 21
São Paulo 21
Sona 20
Brooklyn 19
Mexico City 18
Boston 16
Montreal 15
Guangzhou 12
Tokyo 12
Atlanta 11
Central 11
Johannesburg 11
Melbourne 11
Chicago 10
Paris 10
Canberra 9
Chennai 9
Manchester 9
Milan 9
Charlotte 8
Stockholm 7
Ankara 6
Frankfurt am Main 6
Haikou 6
Redmond 6
Riyadh 6
Jinan 5
Moscow 5
Secaucus 5
Zhengzhou 5
Berlin 4
Copenhagen 4
Hanover 4
Naples 4
Phoenix 4
Poplar 4
Sydney 4
The Dalles 4
Bologna 3
Brownsville 3
Buffalo 3
Camden 3
Chengdu 3
Delhi 3
Denver 3
Handan 3
Ho Chi Minh City 3
Nanyang 3
Newark 3
Oklahoma City 3
Olomouc 3
Orem 3
Pamplona 3
Providence 3
Rabat 3
Sarajevo 3
Taranto 3
Tianjin 3
Vienna 3
Xingtai 3
Almere Stad 2
Amman 2
Anderlecht 2
Andover 2
Baoding 2
Bari 2
Boydton 2
Cervignano del Friuli 2
Changchun 2
Changsha 2
Charleston 2
Cinisello Balsamo 2
Cuijk 2
Douala 2
Dublin 2
Totale 4.217
Salva come PNG Salva come JPEG
Nome #
Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy 215
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 198
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 198
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 197
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 196
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 195
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 195
Apoptosis and autoimmunity induced by clodronate in systemic lupus erythematosus mononuclear circulating cells 194
[Protective effect of verapamil in myocardial hypertrophy due to aortic stenosis experimentally induced in the rat] 191
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 191
[Consensus interferon: a new weapon in the treatment of chronic hepatitis C] 190
Iloprost: an adjunctive approach to chronic viral hepatitis treatment 189
Hepatic Lysosomal Acid Lipase and lipophagy in the progression of NAFLD 189
Impairment of GH/IGF-1 Axis in the liver of patients with hcv-related chronic hepatitis 188
Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients 186
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 186
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 185
Distortion-product otoacoustic emissions: a useful test for monitoring ototoxicity induced by pegylated interferon and ribavirin treatment in patients with chronic hepatitis C 184
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 184
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 184
Retroperitoneal fibrosis and ankylosing spondylitis: which links? 183
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 179
Hepatitis A virus in a medical setting in Madagascar: a lesson for public health 177
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 176
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 176
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients 176
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 175
Granulomatous thyroiditis: an unexpected finding leading to the diagnosis of sarcoidosis 175
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 174
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study 172
Frequency of diabetes and thyroid autoantibodies in patients with autoimmune endocrine disease from Cameroon 171
Blood glucose monitoring in the normal population: the PREDICA study 169
Assessment of liver function by the exhaled breath-print during chronic liver disease 169
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 168
[Hepatocarcinoma: from epidemiology to gene therapy] 166
Approaching the Sarcopenic Patient with Nonalcoholic Steatohepatitis-related Cirrhosis 161
ALEX (R) (artificial liver for extracorporeal xenoassistance): A new bioreactor containing a porcine autologous biomatrix as hepatocyte support. Preliminary results in an ex vivo experimental model 156
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 128
Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications 105
GH-resistance in different stages of chronic liver disease 102
Effectiveness of group medical nutrition therapy in lowering HbA(1c) in type 2 diabetes 102
Anestesia e malattie non comuni 101
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 101
Diabetes in chronic liver disease: from old concepts to new evidence 100
Exhaled breath analysis in hepatology: State-of-the-art and perspectives 99
Enhanced portal flow velocity and volume following Iloprost treatment 98
Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature 97
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 96
[A 73-year-old woman with vomiting and metabolic alkalosis] 96
Altered intestinal transport of amino acids in cirrhotic rats: the effect of insulin-like growth factor-I 95
Radiofrequency ablation of hepatic tissue: a new experimental animal model 94
Growth hormone-stimulated insulin-like factor-1 and acid labile subunit in chronic liver disease 93
Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model 91
A potential experimental model for the study of osteopenia in CCl4 liver cirrhotic rats 91
Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people 90
Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis 88
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 88
Anesthesia & uncommon diseases 88
A challenging alfa-fetoprotein in a cirrhotic patient 86
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 86
Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient 86
The PNPLA3 rs738409 variant can increase the risk of liver toxicity in multiple sclerosis patients treated with beta-interferon 85
Breathprinting of liver diseases 85
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic Patients 84
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 84
[A 74-year-old woman with macrocytic anemia] 83
Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography 83
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 82
[A 61-year-old woman with abdominal pain and urination disorders] 82
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 81
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 80
Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role? 79
Development of a new bioartificial liver using a porcine autologous biomatrix as hepatocyte support 79
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 79
Matched-Pair Analysis of Transplant from Haploidentical, Unmanipulated Bone Marrow Donor versus HLA Identical Sibling for Patients with Hematologic Malignancies: Haploidentical vs HLA Identical Transplantation in Hematologic Malignancies 79
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 78
Donna di 35 anni con febbre, dispnea e dolore alla coscia sinistra [A 35-year-old woman with fever, dyspnea, and pain in the left thigh]. 78
Association between non-alcoholic fatty liver disease and cardiovascular disease: a first message should pass 77
[Ramipril and new therapeutic possibilities for ACE-inhibitors] 74
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs 74
Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis 73
LIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE 73
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 72
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 70
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 68
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 66
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores 65
An overview of deregulated lipid metabolism in nonalcoholic fatty liver disease with special focus on lysosomal acid lipase 64
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 62
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 59
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 56
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 50
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 48
Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers 47
Treatment of symptoms of neuroglycopenia with Glucose Rapid-Spray (TM) to avoid rebound hyperglycaemia 44
Anti-lactoferrin antibodies in systemic lupus erythematosus: isotypes and clinical correlates 42
Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experience 37
TNF-alpha and growth hormone resistance in patients with chronic liver disease 35
The PREDICA study (PREdiction of diabetes from CApillary Blood Glucose) in the general population 35
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 34
Totale 11.685
Salva come PNG Salva come JPEG
Categoria #
all - tutte 101.653
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.653
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022394 0 2 9 0 3 3 4 5 35 10 5 318
2022/2023118 21 1 3 5 5 5 15 4 3 8 45 3
2023/2024824 51 54 25 78 77 333 3 37 13 76 28 49
2024/202512.233 146 74 306 50 192 279 163 39 646 801 4.413 5.124
2025/20261.226 773 390 63 0 0 0 0 0 0 0 0 0
Totale 14.795